[1]
F. Handayani, A. Almahdy, Y. Oktavia Sari, and N. Fitria, “Cost-Effectiveness of Anthracycline, Cyclophosphamide-Taxane (AC-T) Chemotherapy Based on Diagnostic Delay Status: A Payer Perspective”, J Sains Farm Klin, vol. 13, no. 02, pp. 168–182, Aug. 2026.